123 related articles for article (PubMed ID: 12778752)
1. [Study on the hepatocytic cell targetability of liposomes].
Hou XP; Wang L; Wang XT; Li S
Yao Xue Xue Bao; 2003 Feb; 38(2):143-6. PubMed ID: 12778752
[TBL] [Abstract][Full Text] [Related]
2. Increased liver uptake of liposomes and improved targeting efficacy by labeling with asialofetuin in rodents.
Wu J; Liu P; Zhu JL; Maddukuri S; Zern MA
Hepatology; 1998 Mar; 27(3):772-8. PubMed ID: 9500706
[TBL] [Abstract][Full Text] [Related]
3. Circulating cellular fibronectin may be a natural ligand for the hepatic asialoglycoprotein receptor: possible pathway for fibronectin deposition and turnover in the rat liver.
Rotundo RF; Rebres RA; Mckeown-Longo PJ; Blumenstock FA; Saba TM
Hepatology; 1998 Aug; 28(2):475-85. PubMed ID: 9696014
[TBL] [Abstract][Full Text] [Related]
4. [Study on third-type immunoliposomes loaded drugs and the targeting in vitro and in vivo].
Hou XP; Zhang YF; Xie SS; Hu X
Yao Xue Xue Bao; 2001 Jul; 36(7):539-42. PubMed ID: 12585089
[TBL] [Abstract][Full Text] [Related]
5. Low asialoglycoprotein receptor expression as markers for highly proliferative potential hepatocytes.
Ise H; Sugihara N; Negishi N; Nikaido T; Akaike T
Biochem Biophys Res Commun; 2001 Jul; 285(2):172-82. PubMed ID: 11444822
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of a novel galactosylated lipid and its application to the hepatocyte-selective targeting of liposomal doxorubicin.
Wang SN; Deng YH; Xu H; Wu HB; Qiu YK; Chen DW
Eur J Pharm Biopharm; 2006 Jan; 62(1):32-8. PubMed ID: 16226883
[TBL] [Abstract][Full Text] [Related]
7. [Preparation of the EPC and HEPC sterically stabilized doxorubicin liposomes and further studies on pharmacokinetics in rats].
Yu M; Wang Y; Shu G; Zhu Z; Fang S; Wang L
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2008 Jun; 25(3):597-9. PubMed ID: 18693438
[TBL] [Abstract][Full Text] [Related]
8. Targeted delivery of doxorubicin using stealth liposomes modified with transferrin.
Li X; Ding L; Xu Y; Wang Y; Ping Q
Int J Pharm; 2009 May; 373(1-2):116-23. PubMed ID: 19429296
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms of co-modified liver-targeting liposomes as gene delivery carriers based on cellular uptake and antigens inhibition effect.
Zhang Y; Rong Qi X; Gao Y; Wei L; Maitani Y; Nagai T
J Control Release; 2007 Feb; 117(2):281-90. PubMed ID: 17196291
[TBL] [Abstract][Full Text] [Related]
10. Enhanced uptake of lactosaminated human albumin by rat hepatocarcinomas: implications for an improved chemotherapy of primary liver tumors.
Di Stefano G; Fiume L; Bolondi L; Lanza M; Pariali M; Chieco P
Liver Int; 2005 Aug; 25(4):854-60. PubMed ID: 15998437
[TBL] [Abstract][Full Text] [Related]
11. [Effects of different phospholipids on the stabilities of doxorubicin liposomes in vitro and in vivo].
Wang L; Hou BG; Hou XP; Yu ML; Yang JS
Yao Xue Xue Bao; 2001 Jun; 36(6):444-7. PubMed ID: 12585130
[TBL] [Abstract][Full Text] [Related]
12. Prostate cancer-specific monoclonal antibody 5D4 significantly enhances the cytotoxicity of doxorubicin-loaded liposomes against target cells in vitro.
Sawant RM; Cohen MB; Torchilin VP; Rokhlin OW
J Drug Target; 2008 Aug; 16(7):601-4. PubMed ID: 18686131
[TBL] [Abstract][Full Text] [Related]
13. Regulation of asialoglycoprotein receptor expression in the proliferative state of hepatocytes.
Hirose S; Ise H; Uchiyama M; Cho CS; Akaike T
Biochem Biophys Res Commun; 2001 Sep; 287(3):675-81. PubMed ID: 11563848
[TBL] [Abstract][Full Text] [Related]
14. Receptor-mediated transfer of pSV2CAT DNA to mouse liver cells using asialofetuin-labeled liposomes.
Hara T; Aramaki Y; Takada S; Koike K; Tsuchiya S
Gene Ther; 1995 Dec; 2(10):784-8. PubMed ID: 8750019
[TBL] [Abstract][Full Text] [Related]
15. Disaccharide-modified liposomes and their in vitro intracellular uptake.
Song CK; Jung SH; Kim DD; Jeong KS; Shin BC; Seong H
Int J Pharm; 2009 Oct; 380(1-2):161-9. PubMed ID: 19635539
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis and biological evaluation of carbohydrate-functionalized cyclodextrins and liposomes for hepatocyte-specific targeting.
Bernardes GJ; Kikkeri R; Maglinao M; Laurino P; Collot M; Hong SY; Lepenies B; Seeberger PH
Org Biomol Chem; 2010 Nov; 8(21):4987-96. PubMed ID: 20820666
[TBL] [Abstract][Full Text] [Related]
17. [Study on nerve growth factor liposomes on crossing blood-brain barrier in vitro and in vivo].
Xie Y; Ye LY; Cui W; Xu K; Zhang XB; Lou JN; Hou XP
Yao Xue Xue Bao; 2004 Nov; 39(11):944-8. PubMed ID: 15696939
[TBL] [Abstract][Full Text] [Related]
18. In vivo fate of folate-targeted polyethylene-glycol liposomes in tumor-bearing mice.
Gabizon A; Horowitz AT; Goren D; Tzemach D; Shmeeda H; Zalipsky S
Clin Cancer Res; 2003 Dec; 9(17):6551-9. PubMed ID: 14695160
[TBL] [Abstract][Full Text] [Related]
19. Sterically stable liposomes improve the therapeutic effect of hepatic stimulator substance on fulminant hepatic failure in rats.
Li F; Sun JY; Liu M; Lu WY; Wang JY; Shi JY
Biochem Pharmacol; 2011 Sep; 82(5):556-65. PubMed ID: 21664898
[TBL] [Abstract][Full Text] [Related]
20. [Synergistic role between rhIL-2 and adriamycin long circulating temperature-sensitive liposome in targeting therapy on tumor].
Dong LF; Mei HS; Song SX; Lu ZJ
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2005 May; 21(3):296-300. PubMed ID: 15862144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
